TORIPALIMAB PLUS CHEMORADIOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II TRIAL

被引：0
|
作者：
Xu, Xiaoting [1 ]
Huan, Jian [2 ]
Miao, Hui [3 ]
Wang, Hao [4 ]
Wang, Yue [1 ]
Zhu, Hongyu [2 ]
Jiang, Jun [4 ]
Zhou, Juying [5 ]
机构：
[1] First Affiliated Hosp Soochow, Suzhou, Peoples R China
[2] Affiliated Suzhou ScienceandTechnol, Suzhou, Peoples R China
[3] Xuzhou Canc Hosp, Suzhou, Peoples R China
[4] First Affiliated Hosp Anhui, Hefei, Peoples R China
[5] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.357
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
357
引用
收藏
页码：A384 / A384
页数：1
相关论文
共 50 条
  • [1] Toripalimab combined with bevacizumab and chemotherapy for refractory, recurrent or metastatic cervical cancer: preliminary results of a single-arm, open-label, phase II trial
    Peng, Peng
    Yao, Hairong
    Liu, Dantong
    He, Yonglan
    Liu, Shikai
    Xiang, Yang
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 176 : S29 - S29
  • [2] Tucidinostat plus toripalimab in patients with unresectable or metastatic melanoma: An open-label, single-arm phase II study
    Mao, Lili
    Dai, Jie
    Bai, Xue
    Kong, Yan
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Lian, Bin
    Tang, Bixia
    Yan, Xieqiao
    Wang, Xuan
    Li, Siming
    Zhou, Li
    Wei, Xiaoting
    Li, Juan
    Li, Caili
    Duan, Rong
    Xu, Huayan
    Guo, Jun
    Si, Lu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
    Lan, Chunyan
    Shen, Jingxian
    Wang, Yin
    Li, Jundong
    Liu, Zhimin
    He, Mian
    Cao, Xinping
    Ling, Jiayu
    Huang, Jiaming
    Zheng, Min
    Zou, Guorong
    Yan, Haowen
    Liu, Qing
    Yang, Fan
    Wei, Wei
    Deng, Yanhong
    Xiong, Ying
    Huang, Xin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (34)
  • [4] Camrelizumab plus apatinib in patients with advanced cervical cancer: A multicenter, open-label, single-arm, phase II trial.
    Lan, Chunyan
    Huang, Xin
    Shen, Jing-Xian
    Wang, Yin
    Xiong, Ying
    Li, Jundong
    Cao, Xinping
    Deng, Yanhong
    He, Mian
    Zou, Guorong
    Wang, Xiaodi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
    Jie Chen
    Chen Li
    Yuanjie Cao
    Li Zhu
    Bailin Zhang
    Jinqiang You
    Hailing Hou
    Jing Wang
    Zhiyong Yuan
    [J]. BMC Cancer, 22
  • [6] Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
    Chen, Jie
    Li, Chen
    Cao, Yuanjie
    Zhu, Li
    Zhang, Bailin
    You, Jinqiang
    Hou, Hailing
    Wang, Jing
    Yuan, Zhiyong
    [J]. BMC CANCER, 2022, 22 (01)
  • [7] Efficacy and safety of sintilimab plus albumin-bound- paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial
    Wang, Yin
    Zhao, Jing
    Liang, Haixi
    Liu, Junxiu
    Huang, Shenjiao
    Zou, Guorong
    Huang, Xin
    Lan, Chunyan
    [J]. ECLINICALMEDICINE, 2023, 65
  • [8] Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
    Song, Zhengbo
    Lou, Guangyuan
    Wang, Yina
    Yang, Zhiping
    Wang, Wenxian
    Ji, Yongling
    Chen, Shiqing
    Xu, Chunwei
    Hu, Xiao
    Zhang, Yiping
    [J]. BMC MEDICINE, 2022, 20 (01)
  • [9] Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
    Zhengbo Song
    Guangyuan Lou
    Yina Wang
    Zhiping Yang
    Wenxian Wang
    Yongling Ji
    Shiqing Chen
    Chunwei Xu
    Xiao Hu
    Yiping Zhang
    [J]. BMC Medicine, 20
  • [10] Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial
    Hua, Yijun
    You, Rui
    Wang, Zhiqiang
    Huang, Peiyu
    Lin, Mei
    Ouyang, Yanfeng
    Xie, Yulong
    Zou, Xiong
    Liu, Youping
    Duan, Chongyang
    Liu, Yonglong
    Gu, Chenmei
    Liu, Rongzeng
    Yang, Qi
    Jiang, Rou
    Zhang, Mengxia
    Ding, Xi
    Chen, Siyuan
    Lin, Chao
    Sun, Rui
    Chen, Mingyuan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
12345